Pliant Therapeutics, Inc. PLRX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

49/100

2/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Pliant Therapeutics, Inc. (PLRX), dont 32 achats et 16 ventes. Le total des achats d'initiés s'élève à $14.05M et le total des ventes d'initiés à $2.58M.

Les initiés notables ayant une activité récente comprennent Coulie Bernard, Cummings Keith Lamont, Cheung Lily. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — PLRX

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-01-22	Coulie Bernard	President and CEO	Attribution de RSU	1,230,000	$1.30	$1.6M	1,230,000
2026-01-22	Cummings Keith Lamont	Chief Financial Officer	Attribution de RSU	400,000	$1.30	$520K	400,000
2026-01-22	Cheung Lily	Chief Human Resource Officer	Attribution de RSU	300,000	$1.30	$390K	300,000
2026-01-22	Kuo Minnie	Chief Operating Officer	Attribution de RSU	300,000	$1.30	$390K	300,000
2026-01-20	Coulie Bernard	President and CEO	Vente Informative	89,375	$1.28	$114.4K	505,601
2026-01-20	Cummings Keith Lamont	Chief Financial Officer	Vente Informative	24,002	$1.28	$30.72K	297,214
2026-01-20	Cheung Lily	Chief Human Resource Officer	Vente Informative	7,534	$1.28	$9.64K	44,847
2026-01-20	Kuo Minnie	Chief Operating Officer	Vente Informative	6,917	$1.28	$8.85K	37,806
2025-12-10	Kuo Minnie	Chief Operating Officer	Inconnu	55,200	$11.14	$614.93K	-
2025-06-05	Pyott David E I	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-06-05	Crowell Gayle A	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-06-05	Huh Hoyoung	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-06-05	Mccourt Thomas A	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-06-05	Bruhn Suzanne Louise	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-06-05	Curnutte John T	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-06-05	Cline Darren S	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-06-05	Krognes Steve E.	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-06-05	Knobil Katharine	Director	Attribution de RSU	30,000	$1.61	$48.3K	30,000
2025-01-23	Lefebvre Eric	Chief Medical Officer	Attribution de RSU	91,300	$11.14	$1.02M	91,300
2025-01-23	Hull Hans	Chief Business Officer	Attribution de RSU	80,300	$11.14	$894.54K	80,300
2025-01-23	Coulie Bernard	President and CEO	Attribution de RSU	325,000	$11.14	$3.62M	325,000
2025-01-23	Cummings Keith Lamont	Chief Financial Officer	Attribution de RSU	113,300	$11.14	$1.26M	113,300
2025-01-23	Ouimette Mike	General Counsel & Corp. Sec'y	Attribution de RSU	70,000	$11.14	$779.8K	70,000
2025-01-23	Cheung Lily	Chief Human Resource Officer	Attribution de RSU	25,875	-	-	50,425
2025-01-22	Ouimette Mike	General Counsel & Corp. Sec'y	Vente Informative	10,230	$10.99	$112.46K	70,544
2025-01-17	Lefebvre Eric	Chief Medical Officer	Vente Informative	18,478	$11.20	$206.97K	194,574
2025-01-17	Hull Hans	Chief Business Officer	Vente Informative	15,936	$11.20	$178.5K	211,558
2025-01-17	Coulie Bernard	President and CEO	Vente Informative	52,419	$11.20	$587.15K	430,517
2025-01-17	Cummings Keith Lamont	Chief Financial Officer	Vente Informative	20,148	$11.20	$225.68K	262,608
2025-01-17	Ouimette Mike	General Counsel & Corp. Sec'y	Vente Informative	13,270	$11.20	$148.64K	80,774
2025-01-17	Cheung Lily	Chief Human Resource Officer	Vente Informative	3,740	$11.20	$41.89K	24,550
2024-07-10	Lefebvre Eric	Chief Medical Officer	Vente Informative	12,319	$11.56	$142.41K	213,052
2024-07-10	Hull Hans	Chief Business Officer	Vente Informative	9,900	$11.56	$114.44K	227,494
2024-07-10	Coulie Bernard	President and CEO	Vente Informative	38,710	$11.56	$447.49K	482,936
2024-07-10	Cummings Keith Lamont	Chief Financial Officer	Vente Informative	10,911	$11.56	$126.13K	282,115
2024-07-10	Ouimette Mike	General Counsel & Corp. Sec'y	Vente Informative	7,656	$11.56	$88.5K	94,044
2024-07-09	Lefebvre Eric	Chief Medical Officer	Attribution de RSU	24,063	-	-	225,371
2024-07-09	Hull Hans	Chief Business Officer	Attribution de RSU	19,337	-	-	237,394
2024-07-09	Coulie Bernard	President and CEO	Attribution de RSU	75,625	-	-	521,646
2024-07-09	Cummings Keith Lamont	Chief Financial Officer	Attribution de RSU	21,313	-	-	293,026
2024-07-09	Ouimette Mike	General Counsel & Corp. Sec'y	Attribution de RSU	14,954	-	-	101,700
2024-06-13	Pyott David E I	Director	Attribution de RSU	26,764	$13.06	$349.54K	26,764
2024-06-13	Crowell Gayle A	Director	Attribution de RSU	26,764	$13.06	$349.54K	26,764
2024-06-13	Huh Hoyoung	Director	Attribution de RSU	26,764	$13.06	$349.54K	26,764
2024-06-13	Mccourt Thomas A	Director	Attribution de RSU	26,764	$13.06	$349.54K	26,764
2024-06-13	Bruhn Suzanne Louise	Director	Attribution de RSU	26,764	$13.06	$349.54K	26,764
2024-06-13	Curnutte John T	Director	Attribution de RSU	26,764	$13.06	$349.54K	26,764
2024-06-13	Cline Darren S	Director	Attribution de RSU	26,764	$13.06	$349.54K	26,764
2024-06-13	Krognes Steve E.	Director	Inconnu	-	-	-	-
2024-06-13	Krognes Steve E.	Director	Attribution de RSU	53,528	$13.06	$699.08K	53,528

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration